Subscribe

0

  • Sign in with Email

By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.

Don’t have an account? Signup

  • Bookmarks
  • My Profile
  • Log Out
  • NEWS
  • POLICIES
  • MSME OPPORTUNITIES
  • BANKING & FINANCE
  • TECHNOLOGY FOR SMES
  • SECTORS
  • GLOBAL
  • Investment
  • LEGAL
  • KNOWLEDGE QUEST
  • Future Ready Forum 2025
  • Ek Nayi Udaan
  • Future Ready Summit 2024
  • ADVERTISE WITH US
ad_close_btn
  • News
  • Policies
  • Banking & Finance
  • MSME Opportunities
  • Web Stories
  • InFocus
  • Technology For SMEs
  • Sectors
  • Global
  • Fashion

Powered by :

You have successfully subscribed the newsletter.
InFocus Corporate

GSK Pharma Reported 6 % Growth in Q4FY21 at Rs 807 Crore

Total income came in at Rs 837 crore as compared to Rs 791 crore in the same period. Profit before tax for Q4 FY21 stood at Rs 180 crore, marking a growth of 9 per cent.

author-image
SMEStreet Edit Desk
19 May 2021 10:02 IST

Follow Us

New Update
GlaxoSmithKline

GlaxoSmithKline (GSK) Pharmaceuticals clocked 6 per cent growth in revenue for the January to March quarter at Rs 807 crore as compared to the same period of the previous fiscal.

Total income came in at Rs 837 crore as compared to Rs 791 crore in the same period. Profit before tax for Q4 FY21 stood at Rs 180 crore, marking a growth of 9 per cent.

Revenue for the year ended March was Rs 3,194 crore, down 1 per cent versus the previous year with total income at Rs 3,304 at previous year's level.

Profit before tax in FY21 totalled Rs 722 crore as compared to Rs 647 crore in FY20.

The board of directors recommended a dividend of Rs 30 per equity share with a face value of Rs 10 each for FY21.

"Our relentless patient focus helped us revitalise growth through the year and emerge with renewed resilience in Q4 as we notched double-digit growth across some of our focus brands," said Managing Director Sridhar Venkatesh.

"Our established portfolio made gains in respective categories, particularly in the anti-infectives and pain therapeutic areas which have been crucial in the fight against Covid-19," he said in a statement.

GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline Plc, one of the world's leading research-based pharmaceutical and healthcare companies.

Pharmaceutical GlaxoSmithKline
Subscribe to our Newsletter! Be the first to get exclusive offers and the latest news
logo

Related Articles
Read the Next Article
Latest Stories
Subscribe to our Newsletter! Be the first to get exclusive offers and the latest news

Latest Stories
Latest Stories
    Powered by


    Subscribe to our Newsletter!




    Powered by
    Select Language
    English

    Share this article

    If you liked this article share it with your friends.
    they will thank you later

    Facebook
    Twitter
    Whatsapp

    Copied!